A bipartisan bill in New Jersey to cap out-of-pocket health care costs would increase the cost of insurance coverage in the state by as much as $1.9 billion over five years, according to an actuarial analysis by consultancy Oliver Wyman for the Pharmaceutical Care Management Association. A cap would eliminate incentives to choose lower-cost treatments that are as effective as expensive drugs, the analysis found.